CAPR
Capricor Therapeutics, Inc.
There isn't enough reported data to score CAPR yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
CAPR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
CAPR's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CAPR PE Valuation
CAPR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CAPR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAPR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CAPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.64 | -$0.89 |
| Q2 2026 | -$2.45 | -$0.86 |
| Q1 2026 | -$2.32 | -$0.95 |
| Q4 2025 | -$2.26 | -$1.11 |
| Q3 2025 | -$1.75 | -$0.68 |
| Q2 2025 | -$1.59 | -$0.65 |
| Q1 2025 | -$1.37 | -$0.49 |
| Q4 2024 | -$1.15 | -$0.27 |
CAPR lost $2.64 per share over the past year, a bigger loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CAPR on earnings quality, reporting a profit while its opponent remains loss making.
CAPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $11.1M | -7.9% |
| Q3 2024 | $2.3M | -63% |
| Q2 2024 | $4M | +1.4% |
| Q1 2024 | $4.9M | +64% |
| Q4 2023 | $12.1M | +1159% |
| Q3 2023 | $6.2M | +289% |
| Q2 2021 | $204.1K | +309% |
| Q1 2021 | $40.8K | -78% |
UNH has the stronger quarterly revenue trend. Revenue is down 7.9% for CAPR versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -69% | -59 points |
| Q3 2024 | -575% | -464 points |
| Q2 2024 | -292% | -94 points |
| Q1 2024 | -209% | +65 points |
| Q4 2023 | -11% | +830 points |
| Q3 2023 | -111% | +296 points |
| Q2 2023 | -198% | N/A |
| Q1 2023 | -274% | N/A |
CAPR's operating margin was −69% last quarter, down 59 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
CAPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37.5M | -$17.8M |
| Q2 2026 | -$35.5M | -$15.1M |
| Q1 2026 | -$34.4M | -$27M |
| Q4 2025 | -$25.2M | -$9.9M |
| Q3 2025 | -$19.7M | -$8.1M |
| Q2 2025 | -$20.4M | -$8.1M |
| Q1 2025 | -$7.3M | -$5.5M |
| Q4 2024 | -$15.3M | -$3.1M |
CAPR has burned cash in almost every quarter: −$133M over the past year, against −$63M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over CAPR on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +202K shares |
| 1 year | +27% | +12.4M shares |
| 3 years | +129% | +32.8M shares |
| 5 years | +154% | +35.3M shares |
| Available history | +745% | +51.2M shares |
CAPR has 58M diluted shares, up 27% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CAPR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CAPR Net Leverage
CAPR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CAPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 67.4 | Neutral |
CAPR's weekly RSI is 44 (neutral) and its Stochastic is 67 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CAPR PE vs Healthcare Sector
CAPR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CAPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.92 | 29% above |
| 20 week MA | $10.2 | 0.1% above |
| 50 week MA | $20.9 | 51% below |
| 100 week MA | $15.5 | 34% below |
| 200 week MA | $10.8 | 5.4% below |
CAPR has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 5.4% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CAPR on trend strength, trading above more of its moving averages.
CAPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.16 | $3.90 | +236% |
| 2021 | $3.90 | $3.39 | -13% |
| 2022 | $3.39 | $3.52 | +3.8% |
| 2023 | $3.52 | $4.89 | +39% |
| 2024 | $4.89 | $14.1 | +188% |
| 2025 | $14.1 | $29.7 | +111% |
| 2026 YTD | $29.7 | $10.2 | -66% |
CAPR is down 66% so far in 2026, after finishing higher in five of the previous six years.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CAPR on returns for 2026, with the stronger performance.